Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05478213 · ClinicalTrials.gov registry record · NA

Ventricular Tachycardia Mechanisms

A NA study of Ventricular Tachycardia, sponsored by Emory University.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
3
Study locations

NCT05478213 is a NA study of Ventricular Tachycardia that is actively recruiting participants, run by Emory University. The registered enrollment target is 10 participants, below the 288-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (97% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05478213, a NA study of Ventricular Tachycardia, is actively recruiting participants, sponsored by Emory University.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to understand why certain hearts have ventricular arrhythmias and help identify areas of the heart that cause arrhythmias. There is still a significant gap in understanding why ventricular arrhythmias occur. This study will examine the electrical properties of the heart tissue to understand how these arrhythmias occur, and hopefully identify areas that might lead to ventricular arrhythmias. The hope is that studying this might be able to improve outcomes during ventricular tachycardia (VT) ablations.

Conditions Studied

Ventricular Tachycardia

Interventions

  • DEVICE Monophasic Action Potential (MAP) Catheter

Study Locations (3)

Georgia

  • Emory University Hospital Midtown - Atlanta
  • Emory Clinic - Atlanta
  • Emory University Hospital - Atlanta

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2022-10-25
Est. Completion 2026-05
Phase NA

Sponsor

Emory University

1,208 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05478213

The ClinicalTrials.gov registry entry for NCT05478213 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 288-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (97% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ventricular Tachycardia appearing as the primary indexed condition, and to 1 intervention - of which Monophasic Action Potential (MAP) Catheter is the first listed.

NCT05478213 reports 3 study locations spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT05478213 about?

NCT05478213 is a clinical study titled "Ventricular Tachycardia Mechanisms". The purpose of this study is to understand why certain hearts have ventricular arrhythmias and help identify areas of the heart that cause arrhythmias. There is still a significant gap in understanding why ventricular arrhythmias occur. This study will examine the electrical properties of the heart ...

What is the current status of trial NCT05478213?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2022-10-25. Estimated completion is 2026-05.

What conditions does trial NCT05478213 study?

This clinical trial studies the following conditions: Ventricular Tachycardia.

What interventions are being tested in trial NCT05478213?

The interventions under investigation include: Monophasic Action Potential (MAP) Catheter (DEVICE).

Who is sponsoring clinical trial NCT05478213?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05478213 being conducted?

This trial has 3 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Ventricular Tachycardia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Ventricular Tachycardia

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.